ESOPJun 5, 2026, 04:17 PM
Lifecore Biomedical Stockholders Approve 2026 Stock Incentive Plan
AI Summary
Lifecore Biomedical, Inc. stockholders approved the 2026 Stock Incentive Plan at the annual meeting on June 4, 2026. This plan authorizes the issuance of 2,500,000 shares of Common Stock and will become effective on October 16, 2026, replacing the 2019 Plan. Additionally, stockholders elected nine directors, ratified KPMG LLP as the independent auditor for 2026, and approved the non-binding advisory proposal on executive compensation.
Key Highlights
- Stockholders approved the Lifecore Biomedical, Inc. 2026 Stock Incentive Plan.
- The 2026 Plan authorizes 2,500,000 shares of Common Stock for issuance.
- The 2026 Plan will become effective on October 16, 2026, replacing the 2019 Plan.
- Nine directors were elected to the Company's Board of Directors.
- KPMG LLP was ratified as the independent registered public accounting firm for 2026.
- Stockholders approved the non-binding advisory proposal on executive officer compensation.
Price Impact
More from LFCR